News | January 21, 2026
Neurizon locks in global trademark protection across key pharma markets
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The partnership aims to fuse Avantium’s breakthrough materials with Packamama’s expertise in low-emission, innovative wine bottles
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
The Phase 1 study, a non-randomised, open-label, multicentre trial, is evaluating IKS014 in patients with locally advanced or metastatic solid tumours expressing HER2
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Hansoh Pharma will receive an upfront payment in the low double-digit millions
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
Subscribe To Our Newsletter & Stay Updated
